SEC Form 4 · accession 0001127602-16-049044
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Koppel
Officer — EVP, Strategy and Bus. Dev.
Period of report
Apr 6, 2016
Accepted (ET)
Apr 7, 2016 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Apr 6, 2016 | S | 102 | $275.00 | D | 1,848 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- F2Includes 84.8551 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2016.